The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features
Open accessAbstract
The infection caused by methicillin-resistant Staphylococcus aureus (MRSA) is a global threat to public health. Vancomycin remains one of the first-line drugs for the treatment of MRSA infections. However, S. aureus isolates with complete resistance to vancomycin have emerged in recent years. Vancomycin-resistant S. aureus (VRSA) is mediated by a vanA gene cluster, which is transferred from vancomycin-resistant enterococcus. Since the first VRSA isolate was recovered from Michigan, USA in 2002, 52 VRSA strains have been isolated worldwide. In this paper, we review the latest progresses in VRSA, highlighting its resistance mechanism, characteristics of VRSA infections, as well as clinical treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first VRSA case was reported in 2002 in a patient with a catheter-related infection, where molecular analysis identified the presence of the vanA gene, a key determinant of vancomycin resistance [208,209].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [208]
In the citing paper
“Since the first reported case in 2002, VRSA infections have been sporadically identified worldwide (Table 2), with most cases emerging in patients with chronic comorbidities, prior vancomycin exposure, and concurrent infections with VRE [208,277].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [208]
In the citing paper
“While the prevalence remains low, the potential for further adaptation and spread is a primary concern in healthcare settings.”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
The rise of the Enterococcus: beyond vancomycin resistance
Arias, C. A., & Murray, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2761 · Cited by 1,776
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Vancomycin Resistance in Gram-Positive Cocci
Courvalin, P. (2006) · Clinical Infectious Diseases · doi:10.1086/491711 · Cited by 1,028
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Intrinsic and acquired resistance mechanisms in enterococcus
Hollenbeck, B. L., & Rice, L. B. (2012) · Virulence · doi:10.4161/viru.21282 · Cited by 795
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 759
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 694
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Mechanisms of vancomycin resistance in Staphylococcus aureus
Gardete, S., & Tomasz, A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci68834 · Cited by 565
Brent, L. (1983) · PubMed · Cited by 561
Vancomycin resistance in Staphylococcus aureus
Appelbaum, P. C., & Bozdogan, B. (2004) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.03.004 · Cited by 485
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200203000-00016 · Cited by 395
Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story
Walsh, C. T., Fisher, S. L., Park, I.-S., Prahalad, M., & Wu, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90079-4 · Cited by 387
Howden, B. P., McEvoy, C. R. E., Allen, D. L., Chua, K., Gao, W., Harrison, P. F., Bell, J., Coombs, G., Bennett-Wood, V., Porter, J. L., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002359 · Cited by 370
High-level vancomycin-resistant enterococci causing hospital infections
Uttley, A. H. C., George, R. C., Naidoo, J., Woodford, N., Johnson, A. P., Collins, C. H., Morrison, D., Gilfillan, A. J., Fitch, L. E., & Heptonstall, J. (1989) · Epidemiology and Infection · doi:10.1017/s0950268800030478 · Cited by 343
Tiwari, H. K., & Sen, M. R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-156 · Cited by 335
VanA-Type Vancomycin-Resistant Staphylococcus aureus
Périchon, B., & Courvalin, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00346-09 · Cited by 334
Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A., Cook, P., & Wormser, G. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1363 · Cited by 318
Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2276-2285.2000 · Cited by 318
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium
Leclercq, R., Derlot, E., Weber, M., Duval, J., & Courvalin, P. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.10 · Cited by 306
Waldron, D. E., & Lindsay, J. A. (2006) · Journal of Bacteriology · doi:10.1128/jb.00418-06 · Cited by 300
Staphylococcus aureus resistant to vancomycin--United States, 2002.
(2002) · PubMed · Cited by 289
Targeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
SORRELL, T. C., PACKHAM, D. R., SHANKER, S., FOLDES, M., & MUNRO, R. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-344 · Cited by 260
Vancomycin-resistant Staphylococcus aureus--New York, 2004.
(2004) · PubMed · Cited by 252
Production of l-DOPA by Aspergillus terreus
Chattopadhyay, S., & Das, A. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03888.x · Cited by 243
Weigel, L. M., Donlan, R. M., Shin, D. H., Jensen, B., Clark, N. C., McDougal, L. K., Zhu, W., Musser, K. A., Thompson, J., Kohlerschmidt, D., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-06 · Cited by 237
Vancomycin-Resistant Staphylococcus aureus--Pennsylvania, 2002
(2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.17.2116 · Cited by 228
Vancomycin-Resistant Enterococcus faecium in Hospitalized Children
Rubin, L. G., Tucci, V., Cercenado, E., Eliopoulos, G., & Isenberg, H. D. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/648342 · Cited by 217
vanM , a New Glycopeptide Resistance Gene Cluster Found in Enterococcus faecium
Xu, X., Lin, D., Yan, G., Ye, X., Wu, S., Guo, Y., Zhu, D., Hu, F., Zhang, Y., Wang, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-09 · Cited by 213
Vancomycin Revisited – 60 Years Later
Rubinstein, E., & Keynan, Y. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00217 · Cited by 200
Saha, B., Singh, A. K., Ghosh, A., & Bal, M. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47144-0 · Cited by 195
Staphylococcus aureus: A pathogen with still unresolved issues
Rasigade, J.-P., & Vandenesch, F. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.08.018 · Cited by 189
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256
Shlaes, D. M., Bouvet, A., Devine, C., Shlaes, J. H., al-Obeid, S., & Williamson, R. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.198 · Cited by 187
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182 · cited 4×
“Brazil.”
BackgroundInfluentialThati, V., Shivannavar, C. T., & Gaddad, S. M. (2011) · Indian Journal of Medical Research · doi:10.4103/0971-5916.91001 · Cited by 181
Sieradzki, K., & Tomasz, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7103-7110.2003 · Cited by 181
d -Ala- d -Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
Lebreton, F., Depardieu, F., Bourdon, N., Fines-Guyon, M., Berger, P., Camiade, S., Leclercq, R., Courvalin, P., & Cattoir, V. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-11 · Cited by 171
Azimian, A., Havaei, S. A., Fazeli, H., Naderi, M., Ghazvini, K., Samiee, S. M., Soleimani, M., & Peerayeh, S. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01727-12 · Cited by 166
Trends in Antibacterial Use in US Academic Health Centers: 2002 to 2006
Pakyz, A. L., MacDougall, C., Oinonen, M., & Polk, R. E. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.20.2254 · Cited by 162
Kos, V. N., Desjardins, C. A., Griggs, A. D., Cerqueira, G., van Tonder, A. J., Holden, M. T. G., Godfrey, P. A., Palmer, K. L., Bodi, K. L., Mongodin, E. F., et al. (2012) · mBio · doi:10.1128/mbio.00112-12 · Cited by 155
Vancomycin‐ResistantStaphylococcus aureusin the Absence of Vancomycin Exposure
Whitener, C., Park, S. Y., Browne, F. A., Parent, L. J., Julian, K. G., Bozdoğan, B., Appelbaum, P. C., Chaitram, J. M., Weigel, L. M., Jernigan, J. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/382357 · Cited by 148
Corvaglia, A., François, P., Hernández, D., Perron, K., Linder, P., & Schrenzel, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000489107 · Cited by 135
Boyd, D. A., Willey, B. M., Fawcett, D., Gillani, N., & Mulvey, M. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01516-07 · Cited by 135
Hu, Q., Peng, H., & Rao, X. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01601 · Cited by 132
Self-citationVancomycin Resistance VanS/VanR Two-Component Systems
Hong, H., Hutchings, M. I., & Buttner, M. J. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78885-2_14 · Cited by 129
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002505 · Cited by 116
First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
Melo‐Cristino, J., Resina, C., Manuel, V., Lito, L., & Ramirez, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61219-2 · Cited by 116
Challagundla, L., Reyes, J., Rafiqullah, I., Sordelli, D. O., Echániz-Avilés, G., Velázquez-Meza, M. E., Castillo‐Ramírez, S., Fittipaldi, N., Feldgarden, M., Chapman, S. B., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01901 · Cited by 114
Aligholi, M., Emaneini, M., Jabalameli, F., Shahsavan, S., Dabiri, H., & Sedaght, H. (2008) · Medical Principles and Practice · doi:10.1159/000141513 · Cited by 112
Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States
Limbago, B. M., Kallen, A. J., Zhu, W., Eggers, P., McDougal, L. K., & Albrecht, V. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02187-13 · Cited by 101
Mirani, Z. A., & Jamil, N. (2010) · Journal of Basic Microbiology · doi:10.1002/jobm.201000221 · Cited by 100
Acquired Vancomycin Resistance in Clinically Relevant Pathogens
Werner, G., Strommenger, B., & Witte, W. (2008) · Future Microbiology · doi:10.2217/17460913.3.5.547 · Cited by 99
Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization1
Furuno, J. P., Perencevich, E. N., Johnson, J. A., Wright, M., McGregor, J. C., Morris, J. G., Strauss, S. M., Roghmann, M., Nemoy, L. L., Standiford, H. C., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1110.050508 · Cited by 98
Patel, R., Piper, K. E., Cockerill, F. R., Steckelberg, J. M., & Yousten, A. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.705-709.2000 · Cited by 95
Vancomycin-ResistantStaphylococcus aureus,Michigan, USA, 2007
Finks, J. L., Wells, E. V., Dyke, T. L., Husain, N., Plizga, L. A., Heddurshetti, R., Wilkins, M. J., Rudrik, J. T., Hageman, J. C., Patel, J. B., et al. (2009) · Emerging infectious diseases · doi:10.3201/eid1506.081312 · Cited by 86
Rehm, S. J., & Tice, A. D. (2010) · Clinical Infectious Diseases · doi:10.1086/653518 · Cited by 85
Shekarabi, M., Hajikhani, B., Chirani, A. S., Fazeli, M., & Goudarzi, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183607 · Cited by 83
Hu, J., Zhang, X., Liu, X., Chen, C., & Sun, B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04290-14 · Cited by 82
Warren, D. K., Nitin, A., Hill, C., Fraser, V. J., & Kollef, M. H. (2004) · Infection Control and Hospital Epidemiology · doi:10.1086/502357 · Cited by 74
McEvoy, C. R. E., Tsuji, B. T., Gao, W., Seemann, T., Porter, J. L., Doig, K., Ngo, D. T., Howden, B. P., & Stinear, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00279-13 · Cited by 64
Methicillin-Susceptible, Vancomycin-ResistantStaphylococcus aureus, Brazil
Panesso, D., Planet, P. J., Díaz, L., Hugonnet, J., Tran, T. T., Narechania, A., Munita, J. M., Rincón, S., Carvajal, L. P., Reyes, J., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2110.141914 · Cited by 61
Friães, A., Resina, C., MANUEL, V., LITO, L., Ramirez, M., & Melo‐Cristino, J. (2014) · Epidemiology and Infection · doi:10.1017/s0950268814001423 · Cited by 58
Saravolatz, L. D., Pawlak, J., & Johnson, L. B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis492 · Cited by 53
Franchi, D., Climo, M. W., Wong, A. H. M., Edmond, M. B., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/313530 · Cited by 51
Distribution of the vanG-like gene cluster in Clostridium difficile clinical isolates
Ammam, F., Marvaud, J., & Lambert, T. (2012) · Canadian Journal of Microbiology · doi:10.1139/w2012-002 · Cited by 47
Dezfulian, A., Aslani, M. M., Oskoui, M., Farrokh, P., Azimirad, M., Dabiri, H., Salehian, M. T., & Zali, M. R. (2012) · Europe PMC (PubMed Central) · Cited by 44
Périchon, B., & Courvalin, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4281-4285.2004 · Cited by 44
WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108
Peng, H., Hu, Q., Shang, W., Yuan, J., Zhang, X., Liu, H., Zheng, Y., Hu, Z., Yang, Y., Tan, L., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw518 · Cited by 43
Self-citationYoo, J. I., Kim, J. W., Kang, G. S., Kim, H. S., Yoo, J. S., & Lee, Y. S. (2013) · The Journal of Microbiology · doi:10.1007/s12275-013-3088-7 · Cited by 40
Sova, M., Čadež, G., Turk, S., Majce, V., Polanc, S., Batson, S., Lloyd, A. J., Roper, D. I., Fishwick, C. W. G., & Gobec, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.034 · Cited by 40
vanD and vanG -Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora
Domingo, M.-C., Huletsky, A., Giroux, R., Picard, F. J., & Bergeron, M. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00584-07 · Cited by 35
Yousefi, M., Fallah, F., Arshadi, M., Pourmand, M. R., Hashemi, A., & Pourmand, G. (2017) · New Microbes and New Infections · doi:10.1016/j.nmni.2017.05.009 · Cited by 33
Reyes, K., Malik, R., Moore, C. L., Donabedian, S. M., Perri, M. B., Johnson, L., & Zervos, M. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02381-08 · Cited by 30
Kruse, T., Levisson, M., de Vos, W. M., & Smidt, H. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12139 · Cited by 26
Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin.
Hassanzadeh, P., & Arbabi, E. (2012) · Europe PMC (PubMed Central) · Cited by 26
Asadpour, L., & Ghazanfari, N. (2019) · International Microbiology · doi:10.1007/s10123-019-00063-7 · Cited by 24
VanA-Positive Vancomycin–Resistant Staphylococcus aureus
Askari, E., Tabatabai, S. M., Arianpoor, A., & Nasab, M. N. (2012) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31826e8199 · Cited by 22
Heinze, K. D., Kabeto, M. U., Martin, E. T., Cassone, M., Hicks, L., & Mody, L. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2018.09.026 · Cited by 22
Hayakawa, K., Marchaim, D., Bathina, P., Martin, E. T., Pogue, J. M., Sunkara, B., Kamatam, S., Ho, K., Willis, L. B., Ajamoughli, M., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1814-z · Cited by 18
Fasihi, Y., Saffari, F., Mansouri, S., & Kalantar-Neyestanaki, D. (2017) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-017-0562-6 · Cited by 14
(2017) · PubMed Central
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
Denissen, J., Reyneke, B., Waso-Reyneke, M., Havenga, B., Barnard, T., Khan, S., & Khan, W. (2022) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2022.114006 · Cited by 395
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Activity of Specialized Biomolecules against Gram-Positive and Gram-Negative Bacteria
Tavares, T. D., Antunes, J. C., Padrão, J., Ribeiro, A. I., Zille, A., Amorim, M. T. P., Ferreira, F., & Felgueiras, H. P. (2020) · Antibiotics · doi:10.3390/antibiotics9060314 · Cited by 273
Menz, B. D., Charani, E., Gordon, D. L., Leather, A. J., Moonesinghe, S. R., & Phillips, C. J. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s319780 · Cited by 118
Metadata
- Authors
- Cong, Y., Yang, S., & Rao, X.
- Venue
- Journal of Advanced Research
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 21
- Pages
- 169-176
- ISSN
- 2090-1224 (ISSN-L)
- 2090-1232
- OpenAlex
- W2979805180
- Cited by
- 527
- References
- 91
- FWCI
- 28.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.